Free oligosaccharide regulation during mammalian protein N-glycosylation

被引:60
作者
Chantret, Isabelle [1 ,2 ]
Moore, Stuart E. H. [1 ,2 ]
机构
[1] Ctr Rech Biomed Bichat Beaujon, INSERM, U 773, CRB3, F-75018 Paris, France
[2] Univ Paris 7 Denis Didetot, F-75018 Paris, France
关键词
endoplasmic reticulum-associated protein degradation; ERAD; free oligosaccharides; protein N-glycosylation; subcellular transport;
D O I
10.1093/glycob/cwn003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During protein N-glycosylation in mammalian cells, free oligosaccharides (fOS) are generated from lipid-linked oligosaccharides by a pyrophosphatase activity and oligosaccharyltransferase and from misfolded glycoproteins by peptide:N-glycanase in both the ER and cytoplasm. Trafficking machinery comprising oligosaccharide-specific ER and lysosomal transporters, an endo-beta-N-acetyl-glucosaminidase, and the cytosolic M2C1 mannosidase drives a flux of fOS from the ER to cytoplasm and from the cytoplasm into lysosomes where fOS are degraded. Transport of fOS out of the ER is normally efficient and if inhibited causes fOS to be secreted via the Golgi apparatus. By contrast, fOS clearance from the cytosol into lysosomes is less efficient resulting in low micromolar concentrations of fOS in the cytoplasm. Structural analysis of cytosolic fOS reveals oligosaccharide families whose relative abundance highlights the importance of different ER-associated degradation (ERAD) pathways for misfolded glycoproteins and suggests that in liver cells substantial amounts of glycoproteins destined for ERAD may transit early compartments of the Golgi apparatus. Glycoprotein quality control and ERAD are controlled by N-glycan/lectin interactions and the fOS trafficking pathway would seem to ensure that fOS do not interfere with these processes which occur in both the ER and cytoplasm. Although Saccharomyces cerevisiae strains harbouring mutations in genes of the yeast fOS metabolic pathway do not display obvious phenotypes, mammalian fOS are quantitatively more important and the processes leading to their regulation are more complex, raising the possibility that distinct phenotypes will be seen in mammalian cells or animals in which fOS metabolism is modified.
引用
收藏
页码:210 / 224
页数:15
相关论文
共 139 条
[1]   SUBSTRATE-SPECIFICITY OF HUMAN LIVER NEUTRAL ALPHA-MANNOSIDASE [J].
ALDAHER, S ;
DEGASPERI, R ;
DANIEL, P ;
HIRANI, S ;
WARREN, C ;
WINCHESTER, B .
BIOCHEMICAL JOURNAL, 1992, 286 :47-53
[2]   Glucosylated free oligosaccharides are biomarkers of endoplasmicreticulum α-glucosidase inhibition [J].
Alonzi, Dominic S. ;
Neville, David C. A. ;
Lachmann, Robin H. ;
Dwek, Raymond A. ;
Butters, Terry D. .
BIOCHEMICAL JOURNAL, 2008, 409 :571-580
[3]   Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease [J].
Andersson, U ;
Smith, D ;
Jeyakumar, M ;
Butters, TD ;
Borja, MC ;
Dwek, RA ;
Platt, FM .
NEUROBIOLOGY OF DISEASE, 2004, 16 (03) :506-515
[4]  
ANUMULA KR, 1983, J BIOL CHEM, V258, P5274
[5]   Trafficking of the bZIP transmembrane transcription factor CREB-H into alternate pathways of ERAD and stress-regulated intramembrane proteolysis [J].
Bailey, Daniel ;
Barreca, Cristina ;
O'Hare, Peter .
TRAFFIC, 2007, 8 (12) :1796-1814
[6]   The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61β and a cytosolic, deglycosylated intermediary [J].
Bebök, Z ;
Mazzochi, C ;
King, SA ;
Hong, JS ;
Sorscher, EJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29873-29878
[7]  
BELARD M, 1988, BIOCHEM J, V255, P235
[8]  
BISCHOFF J, 1990, J BIOL CHEM, V265, P17110
[9]  
BISCHOFF J, 1983, J BIOL CHEM, V258, P7907
[10]   A glycosylated type I membrane protein becomes cytosolic when peptide:: N-glycanase is compromised [J].
Blom, D ;
Hirsch, C ;
Stern, P ;
Tortorella, D ;
Ploegh, HL .
EMBO JOURNAL, 2004, 23 (03) :650-658